EyePoint Pharmaceuticals Inc. logo

EyePoint Pharmaceuticals Inc. (EYPT)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
13. 30
+0.26
+1.9939%
$
1.15B Market Cap
- P/E Ratio
- Div Yield
1.28M Volume
-1.94 Eps
$ 13.04
Previous Close
Add Transaction
Day Range
12.61 13.69
Year Range
9.4 19.11
Want to track EYPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

EyePoint Pharmaceuticals Inc. (EYPT) Statistics

Valuation metrics

Market Cap 1.15B
Enterprise value 1.06B
Trailing P/E (ttm) -3.8
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) 146.43
Price/Book (mrq) 4.96
Enterprise Value/Revenue 139.16
Enterprise Value/EBITDA -4.07

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.25M
Average volume (90 days) 983.73K

Price summary

52-Week low 9.4
52-Week high 19.11
Beta -
50-Day moving average 13.12
200-Day moving average 14.43

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 9 Dec 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -35.67%
Operating margin -37.01%

Operational effectiveness

Return on assets -0.94%
Return on equity -1.11%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.16
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 2.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 6.66%
Book value per share (mrq) 2.68

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -